Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan

Author： Shiroiwa Takeru   Fukuda Takashi   Tsutani Kiichiro  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.15, Iss.3, 2010-06, pp. : 256-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

By Yaman Emel   Uner Aytug   Er Ozlem   Coskun Ugur   Buyukberber Suleyman   Dikilitas Mustafa   Polat Mevlude   Yamac Deniz   Kaya Ali   Yildiz Ramazan   Ozturk Banu   Benekli Mustafa  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 431-435

Humana Press, Inc

Access to resources Recommend Favorite

XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study

By Rosati Gerardo   Avallone Antonio   Aprile Giuseppe   Butera Alfredo   Reggiardo Giorgio   Bilancia Domenico  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 257-264

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of capecitabine plus oxaliplatin (XELOX): A new first-line option in metastatic colorectal cancer

By Makatsoris Thomas   Kalofonos Haralabos   Aravantinos Gerasimos   Papadimitriou Christos   Kastritis Efstathios   Rigatos Sotirios   Xiros Nikolaos   Petsas Theodore   Economopoulos Theofanis   Sakadamis Athanassios   Fountzilas George  

International Journal of Gastrointestinal Cancer, Vol. 35, Iss. 2, 2005-04 ,pp. : 103-109

Humana Press, Inc

Access to resources Recommend Favorite

Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 9, 2013-11 ,pp. : 1344-1353

Bentham Science Publishers

Access to resources Recommend Favorite

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

By Santini Daniele   Vincenzi Bruno   Schiavon Gaia   Di Seri Marisa   Virzí Vladimir   Spalletta Bruno   Caricato Marco   Coppola Roberto   Tonini Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 613-620

Springer Publishing Company

Access to resources Recommend Favorite